MUSE Trial
Cross-source consensus on MUSE Trial from 1 sources and 6 claims.
1 sources · 6 claims
Preparation
Where it comes from
Other
Other
Other
Highlighted claims
- The MUSE trial is a multicentre, open-label, parallel randomised controlled trial with two arms. — Effect of peri-interventional music on postictal agitation in electroconvulsive therapy patients (MUSE): protocol for an open-label multicentre randomised controlled trial in the Netherlands
- The trial is conducted at two centres in Rotterdam, Netherlands. — Effect of peri-interventional music on postictal agitation in electroconvulsive therapy patients (MUSE): protocol for an open-label multicentre randomised controlled trial in the Netherlands
- The trial is scheduled to run from September 2025 to February 2027. — Effect of peri-interventional music on postictal agitation in electroconvulsive therapy patients (MUSE): protocol for an open-label multicentre randomised controlled trial in the Netherlands
- Eligible participants are adult patients undergoing ECT for major depression at either centre. — Effect of peri-interventional music on postictal agitation in electroconvulsive therapy patients (MUSE): protocol for an open-label multicentre randomised controlled trial in the Netherlands
- The trial is open-label because patients and outcome assessors cannot be blinded to music exposure. — Effect of peri-interventional music on postictal agitation in electroconvulsive therapy patients (MUSE): protocol for an open-label multicentre randomised controlled trial in the Netherlands
- Both centres use etomidate as the only anaesthetic agent to standardise a potential confounder. — Effect of peri-interventional music on postictal agitation in electroconvulsive therapy patients (MUSE): protocol for an open-label multicentre randomised controlled trial in the Netherlands